Advancing chimeric antigen receptor T cell therapy with CRISPR/Cas9
Crossref DOI link: https://doi.org/10.1007/s13238-017-0410-x
Published Online: 2017-04-22
Published Print: 2017-09-01
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Ren, Jiangtao
Zhao, Yangbing http://orcid.org/0000-0003-3041-2535
Version of Record valid from 2023-02-15
License valid from 2017-04-22